KAINOS MEDICINE, INC. Q3 revenue KRW 0.4 billion, operating loss KRW 0.6 billion
KAI summary · Not investment advice
Kainos Med sold KRW 0.4 billion worth in the third quarter and lost KRW 0.6 billion from its main business, versus a KRW 1.5 billion loss a year earlier.
Operating profit · 3 months
KRW -582.2 million
Key facts
- Revenue (3 months)
- KRW 402.1 million
- Net income (3 months)
- KRW -928.3 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 322.2 million
- Revenue (year to date)
- KRW 1.2 billion
- Operating profit (prior-year 3 months)
- KRW -1.5 billion
- Operating profit (year to date)
- KRW -2.6 billion
- Net income (prior-year 3 months)
- KRW -1.8 billion
- Net income (year to date)
- KRW -3.6 billion
Commentary
AI commentary · Not investment advice
What happened
Kainos Medicine reported its consolidated results for the third quarter of 2026. Sales for the latest 3 months were KRW 402.1 million. That is 24.8% more than the same 3 months a year earlier (KRW 322.2 million). It is 1.5% less than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the latest 3 months was a loss of KRW 582.2 million. A year earlier, the loss for the same 3 months was KRW 1.51 billion. Net income (the final profit after taxes and other items) was a loss of KRW 928.3 million. A year earlier, the loss for the same 3 months was KRW 1.84 billion.
What changes for shareholders
For the year to date, sales were KRW 1.18 billion. The operating loss was KRW 2.65 billion. The net loss was KRW 3.56 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist